Results 141 to 150 of about 55,323 (311)

SERUM LIPIDS VS SERUM APOLIPOPROTEINS IN CORD BLOOD [PDF]

, 1977
Walter J. McConathy, Michael P. Curry, Daniel M. Lane, G. Bennett Humphrey   +3 more
openalex   +1 more source

Coronary Plaque Characteristics Assessed by Optical Coherence Tomography and Plasma Lipoprotein(a) Levels in Patients With Acute Coronary Syndrome

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background Lipoprotein(a) [Lp(a)] is associated with increased cardiovascular risk, but its influence on plaque characteristics at optical coherence tomography (OCT) evaluation is not fully understood. Aims This study seeks to explore the impact of Lp(a) levels on plaque morphology as assessed by OCT in a very high‐risk subset of patients ...
Francesca Maria Di Muro, Maria Federica Crociani, Giulia Nardi, Niccolo' Ciardetti, Lucrezia Biagiotti, Elisa Bigi, Francesco Meucci, Miroslava Stolcova, Francesca Ristalli, Emanuele Cecchi, Iacopo Muraca, Renato Valenti, Carlo Di Mario, Alessio Mattesini   +13 more
wiley   +1 more source

Apolipoprotein(a) [PDF]

, 2018
K. J. Lackner, D. Peetz
openaire   +2 more sources

Distribution of apolipoprotein ai-containing lipoprotein subclasses in plasma of normolipidemic subjects.

, 1970
Ragheb F. Atmeh, Amani Z Kasasbeh, Mohammad R Abu Odeh   +2 more
openalex   +2 more sources

Contemporary Perspectives on Chronic Renal Disorders

Chronic Diseases and Translational Medicine, EarlyView.
ABSTRACT The prevalence of renal diseases and its associated burden on healthcare have tremendously risen in the past few years. From simple markers assessing kidney function, current renal research delves into understanding the diseases at the cellular and molecular levels and not just at treating, but at improving quality of life, arresting ...
Deenadhayalan Ashok, Poornima Ajay Manjrekar, Bhushan C. Shetty, Sujina S. S, Rukmini Mysore Srikantiah, Sowndarya Kollampare   +5 more
wiley   +1 more source

A comparison of two methods to investigate the metabolism of human apolipoproteins A-I and and A-II.

, 1978
J. Shepherd, C.J. Packard, A M Gotto, O. David Taunton   +3 more
openalex   +1 more source

Apolipoprotein B [PDF]

, 1978
C. C. Heuck
openalex   +1 more source

Model‐Informed Drug Development Applications and Opportunities in mRNA‐LNP Therapeutics

Clinical Pharmacology &Therapeutics, EarlyView.
The utilization of lipid nanoparticles (LNP) for encapsulating mRNA has revolutionized the field of therapeutics, enabling the rapid development of COVID‐19 vaccines and cancer vaccines. However, the clinical development of mRNA‐LNP therapeutics faces numerous challenges due to their complex mechanisms of action and limited clinical experience.
Jiawei Zhou, Rohit Rao, Monica E. Shapiro, Nessy Tania, Cody Herron, Cynthia J. Musante, Jim H. Hughes   +6 more
wiley   +1 more source

Findings of 18F‐PI‐2620 tau PET imaging in patients with Alzheimer’s disease and healthy controls in relation to the plasma P‐tau181 levels in a Japanese sample

Neuropsychopharmacology Reports, Volume 42, Issue 4, Page 437-448, December 2022., 2022
The present pilot study examined the ability of 18F‐PI‐2620 tau PET tracer to distinguish between healthy control and Alzheimer's disease, as well as correlations with plasma p‐tau181 and cognitive test results. Though the sample size was small, seven for each group, its SUVR in the target brain regions showed distinct differences between them and high
Shogyoku Bun, Sho Moriguchi, Toshiki Tezuka, Yoshiaki Sato, Keisuke Takahata, Morinobu Seki, Shinichiro Nakajima, Yasuharu Yamamoto, Yasunori Sano, Natsumi Suzuki, Ayaka Morimoto, Ryo Ueda, Hajime Tabuchi, Daisuke Ito, Masaru Mimura   +14 more
wiley   +1 more source

Apolipoprotein [PDF]

, 2018
K. J. Lackner, D. Peetz
openaire   +1 more source